Skip to Content


In the US, Lenalidomide (lenalidomide systemic) is a member of the following drug classes: miscellaneous antineoplastics, other immunosuppressants and is used to treat Anemia, Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma and Myelodysplastic Diseases.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Cytostatic agent


Angiogenesis inhibitor

Chemical Names

(3RS)-3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidin-2,6-dion (IUPAC)

(3RS)-3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione (WHO)

Foreign Names

  • Lenalidomidum (Latin)
  • Lenalidomid (German)
  • Lenalidomide (French)
  • Lenalidomida (Spanish)

Generic Names

  • Lenalidomide (OS: BAN, USAN)
  • CC-5013 (IS: Cellgene-Corporation)
  • CC-5053 (IS)
  • CDC-5013 (IS)
  • ENMD-0997 (IS)
  • IMiD3 (IS)

Brand Names

  • Ladevina
    Laboratorio LKM, Vietnam; LKM, Argentina
  • Ledamin
    Aspen, Argentina
  • Revlimid
    Asofarma de Mexico, Mexico; Celgene, Austria; Celgene, Australia; Celgene, Belgium; Celgene, Canada; Celgene, Switzerland; Celgene, Czech Republic; Celgene, Germany; Celgene, Denmark; Celgene, Egypt; Celgene, Spain; Celgene, Finland; Celgene, France; Celgene, United Kingdom; Celgene, Hong Kong; Celgene, Hungary; Celgene, Ireland; Celgene, Israel; Celgene, Iceland; Celgene, Italy; Celgene, Japan; Celgene, Lithuania; Celgene, Latvia; Celgene, Netherlands; Celgene, Norway; Celgene, New Zealand; Celgene, Poland; Celgene, Portugal; Celgene, Sweden; Celgene, Turkey; Celgene, United States; Celgene Europe, Bosnia & Herzegowina; Celgene Europe, Greece; Medical Intertrade, Croatia (Hrvatska); Medicamenta Ecuatoriana, Ecuador; Tecnofarma, Chile


BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.